These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8388218)

  • 1. Pharmacochemistry of the furoxan ring: recent developments.
    Calvino R; Di Stilo A; Fruttero R; Gasco AM; Sorba G; Gasco A
    Farmaco; 1993 Feb; 48(2):321-34. PubMed ID: 8388218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation.
    Calvino R; Fruttero R; Ghigo D; Bosia A; Pescarmona GP; Gasco A
    J Med Chem; 1992 Aug; 35(17):3296-300. PubMed ID: 1324320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
    Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
    Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
    Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
    J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pyridazino[4,5-b]indole derivatives with inodilator and antiaggregatory activities.
    Monge A; Aldana I; Losa MJ; Font M; Cenarruzabeitia E; Castiella E; Frechilla D; Santiago E; Martínez de Irujo JJ; Alberdi E
    Arzneimittelforschung; 1993 Nov; 43(11):1175-80. PubMed ID: 8292060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor.
    Civelli M; Caruso P; Giossi M; Bergamaschi M; Razzetti R; Bongrani S; Gasco A
    Eur J Pharmacol; 1994 Apr; 255(1-3):17-24. PubMed ID: 7517880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No-mimetic furoxans: arylsulphonylfuroxans and related compounds.
    Ferioli R; Fazzini A; Folco GC; Fruttero R; Calvino R; Gasco A; Bongrani S; Civelli M
    Pharmacol Res; 1993; 28(3):203-12. PubMed ID: 8108310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new class of furoxan derivatives as NO donors: mechanism of action and biological activity.
    Ferioli R; Folco GC; Ferretti C; Gasco AM; Medana C; Fruttero R; Civelli M; Gasco A
    Br J Pharmacol; 1995 Feb; 114(4):816-20. PubMed ID: 7773542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of M-nifedipine on contractile responses in isolated atria and coronary vessels: a comparison with nifedipine].
    Rao MR; Liang MD; Liu F; Shen XH; Zou X
    Yao Xue Xue Bao; 1986 May; 21(5):321-5. PubMed ID: 3776539
    [No Abstract]   [Full Text] [Related]  

  • 10. Searching for new NO-donor aspirin-like molecules: Furoxanylacyl derivatives of salicylic acid and related furazans.
    Lazzarato L; Cena C; Rolando B; Marini E; Lolli ML; Guglielmo S; Guaita E; Morini G; Coruzzi G; Fruttero R; Gasco A
    Bioorg Med Chem; 2011 Oct; 19(19):5852-60. PubMed ID: 21906954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.
    Tasso B; Budriesi R; Vazzana I; Ioan P; Micucci M; Novelli F; Tonelli M; Sparatore A; Chiarini A; Sparatore F
    J Med Chem; 2010 Jun; 53(12):4668-77. PubMed ID: 20509610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives.
    Tosco P; Bertinaria M; Di Stilo A; Cena C; Sorba G; Fruttero R; Gasco A
    Bioorg Med Chem; 2005 Aug; 13(15):4750-9. PubMed ID: 15946850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water soluble furoxan derivatives as NO prodrugs.
    Sorba G; Medana C; Fruttero R; Cena C; Di Stilo A; Galli U; Gasco A
    J Med Chem; 1997 Feb; 40(4):463-9. PubMed ID: 9046336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
    Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
    J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of furoxans and benzofuroxans: recent developments.
    Cerecetto H; Porcal W
    Mini Rev Med Chem; 2005 Jan; 5(1):57-71. PubMed ID: 15638792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
    Gordge MP; Hothersall JS; Noronha-Dutra AA
    Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The furoxan system as a useful tool for balancing "hybrids" with mixed alpha 1-antagonist and NO-like vasodilator activities.
    Fruttero R; Boschi D; Di Stilo A; Gasco A
    J Med Chem; 1995 Dec; 38(25):4944-9. PubMed ID: 8523408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of furoxancarbonitriles as a new class of vasodilators.
    Gasco AM; Boschi D; Di Stilo A; Medana C; Gasco A; Martorana PA; Schönafinger K
    Arzneimittelforschung; 1998 Mar; 48(3):212-8. PubMed ID: 9553676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of NO-release from symmetrically substituted furoxans.
    Nirode WF; Luis JM; Wicker JF; Wachter NM
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2299-301. PubMed ID: 16446086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.